Cargando…
HABP2 G534E Variant in Papillary Thyroid Carcinoma
The main nonmedullary form of thyroid cancer is papillary thyroid carcinoma (PTC) that accounts for 80–90% of all thyroid malignancies. Only 3–10% of PTC patients have a positive family history of PTC yet the familiality is one of the highest of all cancers as measured by case control studies. A han...
Autores principales: | Tomsic, Jerneja, Fultz, Rebecca, Liyanarachchi, Sandya, He, Huiling, Senter, Leigha, de la Chapelle, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706330/ https://www.ncbi.nlm.nih.gov/pubmed/26745718 http://dx.doi.org/10.1371/journal.pone.0146315 |
Ejemplares similares
-
Variants in microRNA genes in familial papillary thyroid carcinoma
por: Tomsic, Jerneja, et al.
Publicado: (2016) -
The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017) -
HABP2 p.G534E variant in patients with family history of thyroid and breast cancer
por: Pinheiro, Maisa, et al.
Publicado: (2017) -
A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition
por: Tomsic, Jerneja, et al.
Publicado: (2015) -
The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics
por: Bohórquez, Mabel E, et al.
Publicado: (2016)